Loading clinical trials...
Loading clinical trials...
Lentiviral FIX Gene Therapy for Hemophilia B
Conditions
Interventions
YUVA-GT-F901
Locations
1
China
Shenzhen Geno-immune Medical Institute
Shenzhen, Guangdong, China
Start Date
June 1, 2025
Primary Completion Date
May 31, 2027
Completion Date
June 1, 2028
Last Updated
April 24, 2026
NCT06820515
NCT06379789
NCT06008938
NCT04645199
NCT07080905
NCT06700096
Lead Sponsor
Shenzhen Geno-Immune Medical Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions